Lappe Mark 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:16 pm Purchase | 2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Lappe Mark | 3,184,508 6.700% | 34,794 (+1.10%) | Filing |
| 2021-02-12 4:19 pm Purchase | 2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Lappe Mark | 3,149,714 8.400% | 3,149,714 (New Position) | Filing |